Merck stock in focus before Monday: Cidara deal deadline hits Jan. 6 as MRK sits near 52-week high
Merck shares rose 1.1% to $106.45 Friday, closing just below a 52-week high. Nasdaq said Merck’s tender offer for Cidara Therapeutics expires at 11:59 p.m. ET Jan. 6, with the merger tentatively set ahead of the Jan. 7 market open. Cidara stock is slated to be suspended Jan. 8. Merck’s $0.85 dividend is payable Jan. 8.